SE8002602L - Diagnostiskt forfarande - Google Patents

Diagnostiskt forfarande

Info

Publication number
SE8002602L
SE8002602L SE8002602A SE8002602A SE8002602L SE 8002602 L SE8002602 L SE 8002602L SE 8002602 A SE8002602 A SE 8002602A SE 8002602 A SE8002602 A SE 8002602A SE 8002602 L SE8002602 L SE 8002602L
Authority
SE
Sweden
Prior art keywords
serum
dna
cancer
diagnostic procedure
human beings
Prior art date
Application number
SE8002602A
Other languages
Unknown language ( )
English (en)
Inventor
S T Crooke
L Galvan
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8002602L publication Critical patent/SE8002602L/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G01N2333/4704—Inhibitors; Supressors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]
SE8002602A 1979-04-10 1980-04-03 Diagnostiskt forfarande SE8002602L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2873279A 1979-04-10 1979-04-10

Publications (1)

Publication Number Publication Date
SE8002602L true SE8002602L (sv) 1980-12-09

Family

ID=21845111

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002602A SE8002602L (sv) 1979-04-10 1980-04-03 Diagnostiskt forfarande

Country Status (24)

Country Link
JP (1) JPS55143441A (sv)
KR (1) KR830002502A (sv)
AR (1) AR222700A1 (sv)
AT (1) AT365343B (sv)
AU (1) AU536522B2 (sv)
BE (1) BE882669A (sv)
CH (1) CH644453A5 (sv)
DE (1) DE3013837A1 (sv)
DK (1) DK149980A (sv)
ES (1) ES8103380A1 (sv)
FI (1) FI801078A (sv)
FR (1) FR2454099A1 (sv)
GB (1) GB2047712B (sv)
GR (1) GR67692B (sv)
HU (1) HU183122B (sv)
IE (1) IE49981B1 (sv)
IL (1) IL59772A (sv)
IT (1) IT1143135B (sv)
LU (1) LU82345A1 (sv)
NL (1) NL8002094A (sv)
NO (1) NO801018L (sv)
PH (1) PH15637A (sv)
SE (1) SE8002602L (sv)
ZA (1) ZA802141B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3524644A1 (de) * 1985-07-10 1987-01-15 Heyl Chem Pharm Undulin und dessen peptidfragmente, verfahren zu deren herstellung und ihre verwendung

Also Published As

Publication number Publication date
GB2047712B (en) 1983-02-23
LU82345A1 (fr) 1980-12-16
AU5719380A (en) 1980-10-16
IT8048370A0 (it) 1980-04-09
DK149980A (da) 1980-10-11
BE882669A (fr) 1980-10-06
HU183122B (en) 1984-04-28
FR2454099A1 (fr) 1980-11-07
NO801018L (no) 1980-10-13
ES490396A0 (es) 1981-02-16
ZA802141B (en) 1981-04-29
CH644453A5 (fr) 1984-07-31
AT365343B (de) 1982-01-11
ES8103380A1 (es) 1981-02-16
IE800693L (en) 1980-10-10
IL59772A (en) 1983-05-15
AR222700A1 (es) 1981-06-15
FR2454099B1 (sv) 1984-01-27
DE3013837A1 (de) 1980-10-30
NL8002094A (nl) 1980-10-14
FI801078A (fi) 1980-10-11
IE49981B1 (en) 1986-01-22
IT1143135B (it) 1986-10-22
JPS55143441A (en) 1980-11-08
ATA195780A (de) 1981-05-15
AU536522B2 (en) 1984-05-10
IL59772A0 (en) 1980-06-30
KR830002502A (ko) 1983-05-30
GB2047712A (en) 1980-12-03
GR67692B (sv) 1981-09-07
PH15637A (en) 1983-03-11

Similar Documents

Publication Publication Date Title
ATE196549T1 (de) Immunochemischer nachweiss von endprodukten der fortgeschrittenen glycosylation in vivo
SE8902377D0 (sv) Foerfarande foer framstaellning av ett vaevnadsbindemedel
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
SE8601135L (sv) Kemiskt modifierat hyaluronsyrapreparat och metod for utvinning derav ur djurvevnader
SE8902376D0 (sv) Foerfarande foer framstaellning av ett vaevnadsbindemedel
DK524187D0 (da) Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder
DE69131847D1 (de) Verwendung von kupfer enthaltenden wirkstoffen zur beschleunigung der wundheilung
DE3587941T2 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
DE3880047T2 (de) Zusammensetzung eines zusatzes.
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
KR890007750A (ko) 인간 조직 인자 억제제의 dna 클론
IT7928370A0 (it) Procedimento per determinare l'emoglobina glicosilata in campioni di sangue.
IT7829543A0 (it) Metodo e composizioni per la determinazione diretta del ferro nel siero ematico.
EP0060491A3 (en) Protein pp16, process for concentrating and isolating it, and its use
FI925696A0 (fi) Pao hirudinets aminosyrasekvens baserade trombininhibitorer
DE69129747D1 (de) In lösung bringen von proteinen in aktiver form
SE8002602L (sv) Diagnostiskt forfarande
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
FI885025A (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
ES8505915A1 (es) Metodo de preparar dimetiloctenonas
NO864382D0 (no) Midler for forbedring av proteinabsorpsjon.
IT7947822A0 (it) Composizione per prevenire o curare la dissenteria dei suini e relativo procedimento di impiego
DE3586795D1 (de) Absorptionsverbesserer fuer proteine.
ATE180167T1 (de) Inhibition der ausscheidung von natrium durch die na-k-atpase

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8002602-4